![Rationale and design for TIME: A phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarction]()
Rationale and design for TIME: A phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarctionJay H. Traverse; Timothy D. Henry; Douglas E. Vaughn; Stephen G. Ellis; Carl J. Pepine; James T. Willerson; David X.M. Zhao; Linda B. Piller; Marc S. Penn; Barry J. Byrne; Emerson C. Perin; Adrian P. Gee; Antonis K. Hatzopoulos; David H. McKenna; John R. Forder; Doris A. Taylor; Christopher R. Cogle; Rachel E. Olson; Beth C. Jorgenson; Shelly L. Sayre; Rachel W. Vojvodic; David J. Gordon; Sonia I. Skarlatos; Lemuel A. Moye'; Robert D. Simari · 2009